Directors: Marília Cravo | Sónia Velho | Rui Maio
BODY COMPOSITION AND NUTRITION
The impact of body composition on cancer patients has been the subject of multiple studies during the last years. Studies have shown that depletion of skeletal muscle mass (sarcopenia) as well as an excess of abdominal visceral fat are associated with poor prognosis in several contexts. For instance, increased chemotherapy toxicity in sarcopenic and/or visceral overweight patients, has been demonstrated in neoplastic patients at various sites (breast, pulmonary and digestive).
The association with sarcopenic obesity seems to be even more deleterious than isolated sarcopenia. In surgical patients, association has also been shown with postoperative complications, as well as mortality, especially in patients with digestive neoplasia – colon and rectum, pancreas and stomach. The assessment of various body compartments (muscle mass, subcutaneous and visceral fat, as well as muscle attenuation due to the presence of fat between skeletal muscle fibers) is achieved through a CT scan (for diagnosis/staging of oncologic disease) and analysed with appropriate software. In this session, Prof. Carla Prado from Alberta, Canada, will discuss the impact of body composition analysis in oncologic patients in several contexts. There will also be a practical session.